Senvest Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-162,149
Closed -$4.47M 114
2021
Q2
$4.47M Buy
+162,149
New +$3.19M 0.13% 58

Senvest Management's TBIO Position: Q3 2021 in Review

Senvest Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 162,149 shares — an estimated $4.47M sold.

Senvest Management first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $4.47M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Senvest Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Senvest Management sold 162,149 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $4.47M.
  • Senvest Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Senvest Management's Translate Bio, Inc. Common Stock position peaked at $4.47M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Senvest Management's 13F filing for Q3 2021, filed 12 Nov 2021.